Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander Thompson

Showing results (121-130 of 160) with videos related to

Pageof 16
Sort By:
Health Technology Assessment (Winchester, England)|November 22, 2021
Intravenous or oral antibiotic treatment in adults and children with cystic fibrosis and Pseudomonas aeruginosa infection: the TORPEDO-CF RCTSimon C Langton Hewer, Alan R Smyth, Michaela Brown, et al.
Lancet (London, England)|May 4, 2010
Lipoprotein-associated phospholipase A(2) and risk of coronary disease, stroke, and mortality: collaborative analysis of 32 prospective studies, Alexander Thompson, Pei Gao, et al.
Journal of Gastroenterology and Hepatology|November 14, 2013
Distribution of interferon lambda-3 gene polymorphisms in Australian patients with previously untreated genotype 1 chronic hepatitis C: Analysis from the PREDICT and CHARIOT studiesStuart K Roberts, Joanne Mitchell, Reynold Leung, et al.
Oncotarget|September 11, 2016
Low-dose salinomycin induces anti-leukemic responses in AML and MLLGary D R Roulston, Charlotte L Burt, Laura M J Kettyle, et al.
Hepatology Communications|March 30, 2023
A novel point-of-care test for cirrhosis based on dimeric to monomeric IgA ratio in blood: a pilot cohort studyJessica Howell, Huy Van, Minh D Pham, et al.
The Lancet Regional Health. Western Pacific|January 13, 2022
Assessment of the cost-effectiveness of Australia's risk-sharing agreement for direct-acting antiviral treatments for hepatitis C: a modelling studyDr Nick Scott, Ms Anna Palmer, Mr Tom Tidhar, et al.
Ebiomedicine|June 27, 2018
Initial Identification of a Blood-Based Chromosome Conformation Signature for Aiding in the Diagnosis of Amyotrophic Lateral SclerosisMatthew Salter, Emily Corfield, Aroul Ramadass, et al.
Plos One|May 13, 2021
Antiviral kinetics of tenofovir alafenamide and tenofovir disoproxil fumarate over 24 weeks in women of childbearing potential with chronic HBVCalvin Q Pan, Ting-Tsung Chang, Si Hyun Bae, et al.
Journal of Viral Hepatitis|May 9, 2020
HBV variants are common in the 'immune-tolerant' phase of chronic hepatitis BLilly Yuen, Peter A Revill, Gillian Rosenberg, et al.
Journal of Viral Hepatitis|July 6, 2026
Monitoring of the Cascade of Care in Patients With Chronic HBV in Primary Care Clinics in AustraliaDina Moussa, Jack Wallace, Jacqui Richmond, et al.
Pageof 16

Showing results (121-130 of 160) with videos related to

Sort By:
Pageof 16
Health Technology Assessment (Winchester, England)|November 22, 2021
Intravenous or oral antibiotic treatment in adults and children with cystic fibrosis and Pseudomonas aeruginosa infection: the TORPEDO-CF RCTSimon C Langton Hewer, Alan R Smyth, Michaela Brown, et al.
Lancet (London, England)|May 4, 2010
Lipoprotein-associated phospholipase A(2) and risk of coronary disease, stroke, and mortality: collaborative analysis of 32 prospective studies, Alexander Thompson, Pei Gao, et al.
Journal of Gastroenterology and Hepatology|November 14, 2013
Distribution of interferon lambda-3 gene polymorphisms in Australian patients with previously untreated genotype 1 chronic hepatitis C: Analysis from the PREDICT and CHARIOT studiesStuart K Roberts, Joanne Mitchell, Reynold Leung, et al.
Oncotarget|September 11, 2016
Low-dose salinomycin induces anti-leukemic responses in AML and MLLGary D R Roulston, Charlotte L Burt, Laura M J Kettyle, et al.
Hepatology Communications|March 30, 2023
A novel point-of-care test for cirrhosis based on dimeric to monomeric IgA ratio in blood: a pilot cohort studyJessica Howell, Huy Van, Minh D Pham, et al.
The Lancet Regional Health. Western Pacific|January 13, 2022
Assessment of the cost-effectiveness of Australia's risk-sharing agreement for direct-acting antiviral treatments for hepatitis C: a modelling studyDr Nick Scott, Ms Anna Palmer, Mr Tom Tidhar, et al.
Ebiomedicine|June 27, 2018
Initial Identification of a Blood-Based Chromosome Conformation Signature for Aiding in the Diagnosis of Amyotrophic Lateral SclerosisMatthew Salter, Emily Corfield, Aroul Ramadass, et al.
Plos One|May 13, 2021
Antiviral kinetics of tenofovir alafenamide and tenofovir disoproxil fumarate over 24 weeks in women of childbearing potential with chronic HBVCalvin Q Pan, Ting-Tsung Chang, Si Hyun Bae, et al.
Journal of Viral Hepatitis|May 9, 2020
HBV variants are common in the 'immune-tolerant' phase of chronic hepatitis BLilly Yuen, Peter A Revill, Gillian Rosenberg, et al.
Journal of Viral Hepatitis|July 6, 2026
Monitoring of the Cascade of Care in Patients With Chronic HBV in Primary Care Clinics in AustraliaDina Moussa, Jack Wallace, Jacqui Richmond, et al.
Pageof 16